New Menopause Study Findings Reported from Astellas Pharma Inc. (Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause)

Source :: Women's Health Weekly. December 21, 2023, 96
Publication Year :: 2023
Abstract: 2023 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New study results on menopause have been published. According to news reporting out of [...]

Subjects :: Astellas Pharma Inc. -- Reports
Women -- Health aspects
Desvenlafaxine -- Reports
Conjugated estrogens -- Reports
Menopause -- Care and treatment
Hormones -- Reports
Pharmaceutical industry -- Reports
Health
Women's issues/gender studies

Tools